These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 84053)

  • 21. Effector--target cell interaction of lymph node cells from galactocerebroside-sensitized rats with oligodendrocytes of brain cell cultures.
    Niedieck B; Lohmann U
    J Neuroimmunol; 1981 Jun; 1(2):191-4. PubMed ID: 6978351
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Demyelination in vitro. Absorption studies demonstrate that galactocerebroside is a major target.
    Raine CS; Johnson AB; Marcus DM; Suzuki A; Bornstein MB
    J Neurol Sci; 1981 Oct; 52(1):117-31. PubMed ID: 6170737
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Localization of galactocerebroside in oligodendrocytes, myelin sheath and choroid plexus.
    Uchida T; Takahashi K; Yamaguchi H; Nagai Y
    Jpn J Exp Med; 1981 Feb; 51(1):29-35. PubMed ID: 6171662
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Demyelination in brain cell aggregate cultures, induced by a monoclonal antibody against the myelin/oligodendrocyte glycoprotein (MOG).
    Honegger P; Matthieu JM; Lassmann H
    Schweiz Arch Neurol Psychiatr (1985); 1989; 140(1):10-3. PubMed ID: 2467359
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Galactocerebroside is a specific cell-surface antigenic marker for oligodendrocytes in culture.
    Raff MC; Mirsky R; Fields KL; Lisak RP; Dorfman SH; Silberberg DH; Gregson NA; Leibowitz S; Kennedy MC
    Nature; 1978 Aug; 274(5673):813-6. PubMed ID: 355894
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of antiglycolipid antisera on the lipid composition of cultured mouse spinal cords.
    Saito M; Macala LJ; Roth GA; Bornstein MB; Yu RK
    Exp Neurol; 1986 Jun; 92(3):752-6. PubMed ID: 3709746
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glycolipids and transmembrane signaling: antibodies to galactocerebroside cause an influx of calcium in oligodendrocytes.
    Dyer CA; Benjamins JA
    J Cell Biol; 1990 Aug; 111(2):625-33. PubMed ID: 2166054
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Affinity chromatographic purification of anti-glycolipid antibodies and their application to the membrane studies. Anti-galactocerebroside antibodies.
    Uchida T; Nagai Y
    J Biochem; 1980 Jun; 87(6):1829-41. PubMed ID: 7190564
    [No Abstract]   [Full Text] [Related]  

  • 29. Serological techniques for detection of antibody to galactocerebroside.
    Fry JM; Lisak RP; Manning MC; Silberberg DH
    J Immunol Methods; 1976; 11(2):185-93. PubMed ID: 932445
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myelin-oligodendrocyte glycoprotein (MOG) is a surface marker of oligodendrocyte maturation.
    Scolding NJ; Frith S; Linington C; Morgan BP; Campbell AK; Compston DA
    J Neuroimmunol; 1989 May; 22(3):169-76. PubMed ID: 2649509
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Experimental demyelinating optic neuropathy induced by intra-neural injection of galactocerebroside antiserum.
    Carroll WM; Jennings AR; Mastaglia FL
    J Neurol Sci; 1984 Aug; 65(2):125-35. PubMed ID: 6481395
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-galactocerebroside antibody in rabbits with experimental allergic neuritis.
    Irie H; Yorita T; Takahashi K
    Jpn J Exp Med; 1986 Apr; 56(2):43-9. PubMed ID: 2426483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction of Fab mu of anti-galactocerebroside antibody with galactocerebroside liposomes.
    Das MK; Sarkar DP
    Immunol Lett; 1983 Apr; 6(4):223-6. PubMed ID: 6411612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune response to isolated oligodendrocytes.
    Abramsky O; Lisak RP; Silberberg DH; Brenner T; Pleasure D
    J Neurol Sci; 1979 Sep; 43(1):157-67. PubMed ID: 521826
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peripheral nervous tissue injury induced by galactocerebroside and galactocerebroside immune complexes.
    Tsukada N; Koh CS; Yanagisawa N; Taketomi T; Behan PO
    Acta Neuropathol; 1985; 66(4):274-82. PubMed ID: 2990150
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Search for antibodies to galactocerebroside in the serum and cerebrospinal fluid in human demyelinating disorders.
    Rostami AM; Burns JB; Eccleston PA; Manning MC; Lisak RP; Silberberg DH
    Ann Neurol; 1987 Sep; 22(3):381-3. PubMed ID: 3674803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunological aspects of demyelination.
    Steck AJ
    Bull Schweiz Akad Med Wiss; 1981-1982; ():109-12. PubMed ID: 6191816
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of oligodendrocytes and Schwann cells studied with a monoclonal antibody against galactocerebroside.
    Ranscht B; Clapshaw PA; Price J; Noble M; Seifert W
    Proc Natl Acad Sci U S A; 1982 Apr; 79(8):2709-13. PubMed ID: 7045870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Micromethod of determining antibodies to nerve tissue galactocerebrosides in the complement fixation reaction].
    Luchakova OS; Taranova NP
    Biull Eksp Biol Med; 1987 Dec; 104(12):755-7. PubMed ID: 3689976
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of macroglial cells in rat cerebellum. II. An in situ immunohistochemical study of oligodendroglial lineage from precursor to mature myelinating cell.
    Reynolds R; Wilkin GP
    Development; 1988 Feb; 102(2):409-25. PubMed ID: 2458224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.